GlassScriptPhysician profile
Kalan A Kelch
NPI 1659764124
$1,979.95
in general payments reported to CMS, 2019-2025
23 companies · $786 in 2025
The $786 reported for 2025 was more than what 84% of Acute Care (Nurse Practitioner) providers received nationally (typical 2025 total: $151).
See the full distribution for Acute Care (Nurse Practitioner)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $394 · 2022: $181 · 2024: $620 · 2025: $786.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,406.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,405.88 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $411.95 | 2022-2025 | Eterna, Octrode |
| Collegium Pharmaceutical, INC. | $240.43 | 2021-2025 | Belbuca, Xtampza |
| Valinor Pharma, LLC | $198.99 | 2024-2025 | Movantik |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $139.14 | 2024-2025 | Relistor |
| Avanos Medical | $124.86 | 2021 | |
| Stryker Corporation | $107.67 | 2024 | Mild Device Kit |
| Boston Scientific Corporation | $107.32 | 2022-2025 | General - Pain Management, Wavewriter Alpha Prime 16 |
| Medtronic, INC. | $99.11 | 2025 | Kyphon Express II Kyphopak Tray, Inceptiv, Synchromedii |
| Teva Pharmaceuticals USA, INC. | $72.74 | 2021-2022 | |
| Amgen INC. | $64.99 | 2021 | |
| Allergan, INC. | $63.84 | 2021 | |
| Abbvie INC. | $56.20 | 2022 | |
| Protega Pharmaceutials INC | $52.67 | 2024 | Roxybond |
| Vertex Pharmaceuticals Incorporated | $47.79 | 2025 | |
| Novartis Pharmaceuticals Corporation | $45.05 | 2022-2025 |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Saluda Medical Americas, INC. | $28.89 | 2025 | Evoke |
| Impactortho, INC. | $22.32 | 2025 | |
| Janssen Biotech, INC. | $19.39 | 2025 | Tremfya |
| Tonix Medicines, INC. | $18.41 | 2025 | Tonmya |
| Biodelivery Sciences International, INC. | $16.93 | 2021 | |
| Acacia Pharma INC | $15.11 | 2022 | |
| Hikma Pharmaceuticals USA | $13.86 | 2021 | |
| Grt US Holding, INC. | $12.29 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kalan Kelch listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.